Literature DB >> 12446289

Minimal hippocampal width relates to plasma homocysteine in community-dwelling older people.

Jonathan H Williams1, Erlick A C Pereira, Marc M Budge, Kevin M Bradley.   

Abstract

BACKGROUND: The hippocampus is important for memory. Hippocampal atrophy and higher levels of homocysteine may both predict cognitive dysfunction in community-dwelling older people. We tested if higher homocysteine relates to hippocampal thinning in this group.
SUBJECTS: 156 community-dwelling volunteers without clinical memory problems.
METHOD: We measured minimal hippocampal widths on magnetic resonance images and homocysteine in plasma.
RESULTS: Minimal hippocampal widths related inversely to homocysteine levels.
CONCLUSIONS: Our results indicate that, even in healthy older people, homocysteine may damage the hippocampus. Reducing homocysteine levels in healthy older people may help to prevent Alzheimer's disease.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12446289     DOI: 10.1093/ageing/31.6.440

Source DB:  PubMed          Journal:  Age Ageing        ISSN: 0002-0729            Impact factor:   10.668


  21 in total

1.  The involvement of homocysteine in stress-induced Aβ precursor protein misprocessing and related cognitive decline in rats.

Authors:  Fang Xie; Yun Zhao; Jing Ma; Jing-Bo Gong; Shi-Da Wang; Liang Zhang; Xiu-Jie Gao; Ling-Jia Qian
Journal:  Cell Stress Chaperones       Date:  2016-07-19       Impact factor: 3.667

2.  Memory improvements in elderly women following 16 weeks treatment with a combined multivitamin, mineral and herbal supplement: A randomized controlled trial.

Authors:  Helen Macpherson; Kathryn A Ellis; Avni Sali; Andrew Pipingas
Journal:  Psychopharmacology (Berl)       Date:  2011-10-18       Impact factor: 4.530

Review 3.  Differential aging of the brain: patterns, cognitive correlates and modifiers.

Authors:  Naftali Raz; Karen M Rodrigue
Journal:  Neurosci Biobehav Rev       Date:  2006-08-17       Impact factor: 8.989

Review 4.  Age-related lysosomal dysfunction: an unrecognized roadblock for cobalamin trafficking?

Authors:  Hua Zhao; Ulf T Brunk; Brett Garner
Journal:  Cell Mol Life Sci       Date:  2011-10-21       Impact factor: 9.261

Review 5.  Is hyperhomocysteinemia an Alzheimer's disease (AD) risk factor, an AD marker, or neither?

Authors:  Jia-Min Zhuo; Hong Wang; Domenico Praticò
Journal:  Trends Pharmacol Sci       Date:  2011-06-20       Impact factor: 14.819

Review 6.  Lowering homocysteine levels with folic acid and B-vitamins do not reduce early atherosclerosis, but could interfere with cognitive decline and Alzheimer's disease.

Authors:  Federico Cacciapuoti
Journal:  J Thromb Thrombolysis       Date:  2013-10       Impact factor: 2.300

7.  Greater intake of vitamins B6 and B12 spares gray matter in healthy elderly: a voxel-based morphometry study.

Authors:  Kirk I Erickson; Barbara L Suever; Ruchika Shaurya Prakash; Stanley J Colcombe; Edward McAuley; Arthur F Kramer
Journal:  Brain Res       Date:  2008-01-26       Impact factor: 3.252

8.  Cobalamin deficiency, hyperhomocysteinemia, and dementia.

Authors:  Steven F Werder
Journal:  Neuropsychiatr Dis Treat       Date:  2010-05-06       Impact factor: 2.570

9.  Homocysteine-lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: a randomized controlled trial.

Authors:  A David Smith; Stephen M Smith; Celeste A de Jager; Philippa Whitbread; Carole Johnston; Grzegorz Agacinski; Abderrahim Oulhaj; Kevin M Bradley; Robin Jacoby; Helga Refsum
Journal:  PLoS One       Date:  2010-09-08       Impact factor: 3.240

10.  Plasma Total Homocysteine Levels are not Associated with Medial Temporal Lobe Atrophy, but with White Matter Changes in Alzheimer's Disease.

Authors:  Sung Rae Kim; Seong Hye Choi; Choong Kun Ha; Shin Goo Park; Hae Wook Pyun; Dae Hyun Yoon
Journal:  J Clin Neurol       Date:  2009-06-30       Impact factor: 3.077

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.